TB
Theravance Biopharma Inc (TBPH)
NASDAQ·Healthcare·Biotechnology
$16.88
+0.03%
Mkt Cap $873.31M
Analyst Ratings
Buy
4
Hold
6
Sell
0
Price Target (8 analysts)
$15.50
Range $14.00 – $17.00
Implied Upside
-8.1%
Consensus $15.50 vs current $16.88
NASDAQ·Healthcare·Biotechnology
$16.88
+0.03%
Mkt Cap $873.31M
Buy
4
Hold
6
Sell
0
Price Target (8 analysts)
$15.50
Range $14.00 – $17.00
-8.1%
Consensus $15.50 vs current $16.88